Table of Contents
THC-O is federally illegal (DEA Schedule I, 2023; P.L. 119-37, November 2026) and uniquely risky to vape (ketene formation from heated acetate esters). Anyone seeking what THC-O promised β strong effects, or relief without smoking β has better options. Here are seven, graded honestly. None is risk-free; all are better studied or better regulated than THC-O.
7 options
1. State-licensed Delta-9 THC (where legal)
The best-studied psychoactive cannabinoid, with mandatory testing in legal markets. Modest evidence for chronic pain and MS symptoms (per the NCCIH cannabis overview). See our THC effects guide.
2. CBD
Non-psychoactive, human trials, one FDA-approved medicine (Epidiolex). Known risks: liver injury, CYP450 interactions, drowsiness. Not a THC-O replacement for anyone seeking intoxication β a different tool entirely. See our CBD vs THC guide.
3. CBG
Non-psychoactive, no human trials. Preclinical only (MRSA in vitro, mouse IBD model, one 1990 cat eye-pressure study). Better than THC-O on safety unknowns, but unproven for any use. See our CBG guide.
4. CBN
Weakly psychoactive (~1/10 THC). Sleep evidence very limited (Karniol 1975 tested CBN with THC, not alone; Corroon 2021). No established dose. See our CBN science guide.
5. CBC
Non-psychoactive, no human trials. Preclinical pain/inflammation signals via TRP channels. No anti-depressant evidence β that claim should be disregarded.
6. THCV
Dose-dependent: CB1 antagonist at low doses, agonist at high doses. One small trial (Jadoon 2016, n=62) found reduced fasting glucose in type-2 diabetes β not weight loss. Unreplicated. No established dose.
7. Non-cannabinoid approaches
For sleep, pain, or anxiety: the evidence-based options (CBT-I, exercise, approved medications) outperform every unproven cannabinoid. A clinician can help β especially given cannabinoid drug interactions.
What NOT to substitute
| Substitute | Why not |
|---|---|
| Delta-8 / HHC / THCP | Converted/synthesized cannabinoids β lost hemp status under P.L. 119-37; unregulated, unstudied in humans |
| “Designer” cannabinoids | Novel compounds with zero human data; the “legal advantage” loophole closed in late 2026 |
| Any vaped acetate | Ketene risk from heated acetate esters |
The FDA’s warnings on unregulated converted cannabinoids apply to every product in this table. See our THC-O legal history.
Frequently asked questions
What are THC-O alternatives?
State-licensed THC (where legal), CBD, CBG, CBN, CBC, THCV, and non-cannabinoid approaches β each with different evidence, risks, and legal status.
Why opt for THC-O substitutes?
THC-O is federally illegal, unstudied in humans, and uniquely risky to vape (ketene). Every alternative above is better studied or better regulated.
How do THC-O alternatives differ?
Psychoactivity (THC yes; CBD/CBG/CBC no; CBN weak; THCV dose-dependent), evidence (THC/CBD extensive; rest preclinical), and legality (state-licensed vs unregulated).
Can THC-O substitutions ensure safety?
No substance is risk-free. CBD has the best-documented safety profile; state-licensed THC has mandatory testing. Unregulated products of any kind carry contamination and labeling risks.
Is CBD a viable THC-O counterpart?
For non-intoxicating use, yes β with real evidence and known risks. For intoxication, no β CBD is not psychoactive and cannot substitute for THC-O’s effects.
Browse the THC & Cannabinoids hub.
Affiliate Disclosure
The CakeHeights Editorial Team is committed to providing accurate, research-backed information about cannabis and hemp products. Some links on this page are affiliate links, meaning we may earn a commission at no extra cost to you if you make a purchase through them. Our recommendations are based on independent research, testing, and analysis. We only promote products we believe offer genuine value to our readers. Learn more β